MedPath

Subjects With T2D or at Risk of T2D Cohort Follow-up

Active, not recruiting
Conditions
Diabetes Mellitus, Type 2
Interventions
Other: Questionnaire
Diagnostic Test: OGTT
Other: HbA1c
Registration Number
NCT05567692
Lead Sponsor
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
Brief Summary

The main objective of this study is to prospectively follow the subjects included in "Descendance" cohort and to describe the occurrence of type 2 diabetes in non-diabetic subjects, which will allow us to iteratively update the "Descendance" Type 2 Diabetes risk prediction model.

Detailed Description

High risk families will be prospectively follow in order to better understand the risk of transmission of type 2 diabetes from one generation to another. The cohort will also allow us to collect additional data on diabetic patients.

The monitoring of the cohort will take place for at least 10 years with a follow-up of all participants every three years. To detect individuals who develop dysglycemia during the study, a glucose tolerance test (GTT) and HbA1c measurement will be conducted.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
837
Inclusion Criteria
  • Subjects have participated in the Descendance study
  • Subjets who sign informed consent to participate in the study
Exclusion Criteria
  • Subjects not enrolled in Descendance study
  • Subjects refusing to participate
  • Pregnant or breastfeeding
  • Subjects in emergency situations, under legal protection or unable to provide informed -consent
  • Subjects lost to follow-up or died

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
T2D groupQuestionnairesubjects with type 2 diabetes
Non-T2D groupHbA1chealthy subjects
Non-T2D groupQuestionnairehealthy subjects
Non-T2D groupOGTThealthy subjects
Primary Outcome Measures
NameTimeMethod
Type 2 diabetes incidence in Descendance population9years

Presence of type 2 diabetes mellitus, on basis of self-reported (physician diagnosis) or diagnosed by OGTT and HbA1c

Secondary Outcome Measures
NameTimeMethod
Provide estimates of prevalence of diabetes and prediabetes in Descendance populationat baseline, 3-, 6- and 9-years follow-up

To estimate the prevalence of undiagnosed diabetes mellitus and pre-diabetes in Descendance population

Study of interactions between risk factors on type 2 diabetes incidenceat baseline, 3-, 6- and 9-years follow-up

Self-administered questionnaire. "Descendance" specific questionnaire

Trial Locations

Locations (1)

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

🇫🇷

Évry, France

© Copyright 2025. All Rights Reserved by MedPath